Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction:

Adam D DeVore1,2, Anne S Hellkamp1, Laine Thomas1

  • 1Duke Clinical Research Institute, Durham, NC (A.D.D., A.S.H., L.T., A.F.H.).

Insights

Improvements in left ventricular ejection fraction (LVEF) are common in heart failure (HF) patients. Shorter HF duration and nonischemic cardiomyopathy predict better LVEF recovery in routine care.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Outcomes

Background:

  • Left ventricular ejection fraction (LVEF) improvement is a key goal in heart failure (HF) with reduced EF.
  • Factors influencing LVEF improvement in clinical practice are not well-defined.

Purpose of the Study:

  • To identify patient factors associated with LVEF improvement in routine clinical practice among outpatients with HF with reduced EF.
  • To describe the characteristics of patients likely to experience LVEF recovery.

Main Methods:

  • Analysis of data from the prospective CHAMP-HF registry.
  • Inclusion of 2623 outpatients with HF with reduced EF who had baseline and follow-up LVEF assessments.
  • Multivariable modeling to identify factors associated with LVEF increase.

Main Results:

  • Nearly half (49%) of patients experienced a ≥5% increase in LVEF, and 34% had a ≥10% increase.
  • Factors associated with ≥5% LVEF increase included shorter HF duration, no implantable cardioverter-defibrillator, lower baseline LVEF, nonischemic cardiomyopathy, and no coronary disease.
  • Median LVEF improved by 4% from a baseline of 30%.

Conclusions:

  • LVEF improvements are common in outpatients with chronic HF with reduced EF.
  • Specific baseline cardiac characteristics identify patients more likely to achieve LVEF recovery.
  • Findings can inform clinical decisions and guide future research on myocardial recovery.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
143
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
205
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
164
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
573
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
261